Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab

Published:2014-12 Issue:10 Volume:30 Page:842-846
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Altun Ahmet¹,Kurna Sevda Aydin¹,Olcaysu Osman Okan²,Sengor Tomris³,Aki Suat Fazil¹,Atakan Tugba Gencaga¹

Affiliation:

1. Fatih Sultan Mehmet Education and Research Hospital, Clinic of Ophthalmology, Istanbul, Turkey.

2. Erzurum Region Education and Research Hospital, Clinic of Ophthalmology, Erzurum, Turkey.

3. Department of Ophthalmology, Bilim University, Istanbul, Turkey.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2014.0043

Reference30 articles.

1. Digital Indocyanine Green Videoangiography of Central Serous Chorioretinopathy

2. CENTRAL SEROUS CHORIORETINOPATHY AND INDOCYANINE GREEN ANGIOGRAPHY

3. Optical Coherence Tomography of Central Serous Chorioretinopathy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of anti‐VEGF efficacy in chronic central serous chorioretinopathy based on intraocular cytokine levels and pigment epithelium detachment subtypes;Acta Ophthalmologica;2022-02-04

2. Evaluation of the effect of intravitreal antivascular endothelial growth factor versus medical treatment in acute central serous chorioretinopathy;Journal of the Egyptian Ophthalmological Society;2022

3. Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy;PLOS ONE;2020-09-08

4. Pharmacotherapy of Central Serous Chorioretinopathy: A Review of the Current Treatments;Current Pharmaceutical Design;2019-03-20

5. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser;Graefe's Archive for Clinical and Experimental Ophthalmology;2017-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3